deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01867697

Nordic 8 - A Phase II Trial

Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II Trial

Sponsor: Merck Serono International SA

Updated 9 times since 2017 Last updated: Oct 29, 2020 Started: May 31, 2012 Primary completion: Mar 31, 2019 Completion: Mar 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01867697, this PHASE2 trial focuses on Metastatic Colorectal Cancer and remains completed. Sponsored by Merck Serono International SA, it has been updated 9 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotUnknown Status~Sep 2018 – ~Sep 2020 · 24 months · monthly snapshotActive Not Recruiting~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshotUnknown Status~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown StatusCompleted

Show 4 earlier versions
  1. Sep 2020 — Nov 2020 [monthly]

    Unknown Status PHASE2

    Status: Active Not RecruitingUnknown Status

  2. Sep 2018 — Sep 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown StatusActive Not Recruiting

  3. Jun 2018 — Sep 2018 [monthly]

    Unknown Status PHASE2

  4. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Merck Serono International SA
  • Per Pfeiffer
Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .